Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

NCT01266213 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

147

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Estrogen Receptor Positive Tumor
Breast Cancer Nos Premenopausal

Interventions

DRUG: Fulvestrant plus Goserelin
DRUG: Anastrozole plus Goserelin
DRUG: Goserelin

Sponsor

Samsung Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]